Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)

被引：0
|
作者：
Pulusu, S. S. R. [1 ]
Srinivasan, A. [2 ]
Krishnaprasad, K. [3 ]
Cheng, D. [4 ]
Mogilevski, T. [5 ]
Flanagan, E. [6 ]
Keung, C. [7 ]
Wu, C. [8 ]
Prosser, R. [9 ]
Sawyer, E. [10 ]
Rizvi, Q. -U. -A. [11 ,12 ]
Su, H. [13 ]
Leung, W. -K. [14 ]
Edmundson, A. [3 ,14 ]
Cooke, S. [15 ]
Mahy, G. [15 ]
Thin, L. [16 ]
Radford-Smith, G. [3 ]
Sparrow, M. [13 ]
Andrews, J. M. [11 ,12 ]
Connor, S. [10 ]
Bampton, P. [9 ]
Ghaly, S. [8 ]
Van Langenberg, D. [7 ]
Bell, S. [6 ]
De Cruz, P. [5 ]
Begun, J. [4 ]
Ng, S. [14 ]
Travis, S. [2 ]
Lawrance, I. [1 ]
机构：
[1] St John God Subiaco, IBD Ctr, Perth, WA, Australia
[2] Oxford Univ Hosp, Oxford, England
[3] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[4] Mater Hosp, Brisbane, Qld, Australia
[5] Austin Hlth, Melbourne, Vic, Australia
[6] St Vincents Hosp, Melbourne, Vic, Australia
[7] Eastern Hlth, Melbourne, Vic, Australia
[8] St Vincents Hosp, Sydney, NSW, Australia
[9] Flinders Med Ctr, Adelaide, SA, Australia
[10] Liverpool Hosp, Sydney, NSW, Australia
[11] Royal Adelaide Hosp, Adelaide, SA, Australia
[12] Univ Adelaide, Adelaide, SA, Australia
[13] Alfred Hosp, Melbourne, Vic, Australia
[14] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[15] Townsville Hosp, Townsville, Qld, Australia
[16] Fiona Stanley Hosp, Perth, WA, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P571
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [1] VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)
    Pulusu, Samba Siva Reddy
    Srinivasan, Ashish
    Krishnaprasad, Krupa
    Cheng, Daniel
    Mogilevski, Tamara
    Flanagan, Emma
    Keung, Charlotte
    Wu, Yang
    Prosser, Ruth
    Sawyer, Elise A.
    Rizvi, Quart-Ul-Ain
    Su, Heidi Y.
    Leung, Wai K.
    Edmundson, Aleksandra
    Cooke, Sharon
    Mahy, Gillian
    Thin, Lena
    Radford-Smith, Graham L.
    Sparrow, Miles
    Andrews, Jane M.
    Connor, Susan J.
    Bampton, Peter A.
    Simon, Ghaly
    van Langenberg, Daniel R.
    Bell, Sally
    De Cruz, Peter
    Begun, Jakob
    Ng, Siew C.
    Travis, Simon P.
    Lawrance, Ian
    GASTROENTEROLOGY, 2018, 154 (06) : S836 - S836
  • [2] Efficacy of Vedolizumab (VDZ) by Disease Extension in Ulcerative Colitis (UC)
    Michetti, Pierre
    Braegger, Fiona
    Kempf, Christian
    Allez, Matthieu
    SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [3] The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
    Ye, Byong Duk
    Cheon, Jae Hee
    Song, Ki Hwan
    Kim, Joo Sung
    Kim, Young-Ho
    Yoon, Hyuk
    Lee, Kang-Moon
    Kang, Sang-Bum
    Jang, Byung Ik
    Park, Jae Jun
    Kim, Tae Oh
    Lee, Dae-Wook
    Foo, Chee Yoong
    Shin, Jeong Eun
    Park, Dong Il
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [4] Efficacy of vedolizumab (VDZ) by disease extension in ulcerative colitis
    Michetti, P.
    Braegger, F.
    Kempf, C.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S402 - S403
  • [5] Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center
    Hoffmann, Peter
    Krisam, Johannes
    Stremmel, Wolfgang
    Gauss, Annika
    DIGESTIVE DISEASES, 2019, 37 (01) : 33 - 44
  • [6] Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
    Ito, A.
    Shun, M.
    Teppei, O.
    Katsutoshi, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S377 - S378
  • [7] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [8] Comparison of Real-World Outcomes of Adalimumab (ADA) and Infliximab (IFX) for Patients With Ulcerative Colitis (UC) in the United States
    Sandborn, William
    Sakuraba, Atsushi
    Ozbay, A. Burak
    Sorg, Rachael A.
    Reichmann, William
    Chao, Jingdong
    Skup, Martha
    GASTROENTEROLOGY, 2015, 148 (04) : S272 - S272
  • [9] A SINGLE-CENTRE, REAL-WORLD EXPERIENCE OF TREATING ULCERATIVE COLITIS PATIENTS WITH VEDOLIZUMAB
    Lenti, M. V.
    Cococcia, S.
    Giuffrida, P.
    Aronico, N.
    Soriano, S.
    Corazza, G. R.
    Di Sabatino, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E202 - E203
  • [10] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
12345